An open-label clinical trial of dopamine agonists in treatment-resistant depression.
Phase of Trial: Phase II
Latest Information Update: 26 Jun 2012
At a glance
- Drugs Cabergoline (Primary) ; Pramipexole (Primary) ; Ropinirole (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- 26 Jun 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 28 Dec 2010 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 11 Jul 2009 New trial record